Alkermes Highlights Signs and Symptoms of Schizophrenia | News Direct

Alkermes Highlights Signs and Symptoms of Schizophrenia

News release by Alkermes

facebook icon linkedin icon twitter icon pinterest icon email icon Northampton, MA | January 31, 2022 12:00 PM Eastern Standard Time

Schizophrenia is a complex brain disorder that can significantly impact patients. Fortunately, there are treatment options that may help.

Learn more about the signs, symptoms, and treatments from National Institute of Mental Health (NIMH).

About AlkermesAlkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com